Stem Cell Research Technology
Neuralstem, Inc. is a publicly traded biotherapeutics company whose mission is to apply stem cell research and its patented human neural stem cell technology to treat diseases of the central nervous system including Ischemic Paraplegia, Traumatic Spinal Cord Injury, ALS and Parkinson’s Disease.
Pursuing medical advances through therapeutic cloning can help millions of those who suffer from diseases and injuries to one day have fuller memories, be able to walk, be pain free, and not suffer from chronic heart disease. It is past time to put aside ideology and put first the interests of those individuals and their families who are suffering many needlessly.
Find out more about our Stem Cell Research Technology
